Infection of the lungs of immunodeficient mice with the paramyxovirus simian virus 5 (SV5) was prolonged compared with the time course of infection in immunocompetent mice. Although there was a significant increase in both viral RNA and proteins, little infectious virus was produced. Adoptive transfer of immune lymphocytes (isolated from the spleens of mice previously infected with SV5) but not of nonimmune lymphocytes increased the speed of clearance of virus from the lungs of immunodeficient mice. In contrast, passive transfer of a pool of neutralizing monoclonal antibodies specific for the HN and F glycoproteins of SV5 did not have a significant effect on the speed of clearance of virus. Furthermore, no significant increase in the rate of virus clearance was observed upon adoptive transfer of purified immune B lymphocytes to SV5-infected immunodeficient mice despite production by the mice of high titers of neutralizing antibodies. Evidence is presented that CD8+ effector cells are primarily responsible for the clearance observed. The general significance of these results with respect to immune clearance of persistent virus infections is discussed.
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Paramyxoviruses can cause persistent infections in vitro and in vivo; in such infections, only small amounts of infectious virus may be produced but virus RNA and proteins can be detected over prolonged periods of time. In vivo, such infections may have a number of important consequences for both the host and the virus (R. E. Randall and W. C. Russell, in D. W. Kingbury, ed., The Paramyxoviruses, in press). Indeed, a number of chronic human diseases have been shown to be either caused by persistent paramyxovirus infections (e.g., measles and subacute sclerosing panencephalitis; 25) or linked with such infections (e.g., Paget's bone disease, autoimmune chronic active hepatitis, and multiple sclerosis; reviewed by Randall and Russell [ in press]). Nevertheless, it appears that before the establishment of a persistent infection in vivo, the infected individual often survives the acute infection in a normal fashion. There are therefore two major questions that need to be addressed in such situations: (i) what are the molecular mechanisms involved in the establishment of persistent paramyxovirus infections, and (ii) why does the immune system fail to clear the persistent infection when it copes successfully with the acute infection.
An acute virus infection is normally controlled through the induction and interaction of specific antibody and cellmediated immune responses. Antibodies are primarily concerned with the inactivation, or neutralization, of free virus, whereas cytotoxic T lymphocytes (CTLs) recognize and kill virus-infected cells and thus prevent or reduce the release of progeny virus. T lymphocytes may also mediate antiviral activity through the release of lymphokines, such as gamma interferon. T lymphocytes recognize virus antigens in association with either class I or class II Previous work has shown that CTLs play a major role in clearing both orthomyxovirus and paramyxovirus infections from infected mouse lungs (5, 14, 24, 27) . There have also been numerous reports demonstrating that antibodies to the surface glycoproteins of these viruses are protective in vivo (8, 13, 21, 23, 26, 28) . In these cases, it is generally agreed that the protection observed is mainly due to the ability of these antibodies to neutralize virus infectivity. We have previously shown that a prototype paramyxovirus, simian virus 5 (SV5), is capable of infecting mouse lungs and that immunization with either internal or external structural proteins as solid matrix-antibody-antigen complexes increases the speed of clearance of the virus from the lungs. However, in these studies there was no correlation between the speed of clearance and the level of serum-neutralizing antibodies in immunized mice (20) Western blot analysis of lung extracts from SV5-infected mice. Lungs were homogenized in SDS-polyacrylamide gel electrophoresis disruption buffer, sonicated by using an MSE ultrasonic probe, and heated for S min at 100°C. Particulate material was pelleted by centrifugation (6,000 x g for 3 min), and the dissociated polypeptides were separated by electrophoresis through a 15% SDS-polyacrylamide slab gel. The separated polypeptides were transferred to nitrocellulose by using a semidry gel electroblotter. The nitrocellulose was then reacted with a pool of MAbs to the P protein (19) , and bound antibody was detected by 1251_ labeled protein A and autoradiography as previously described (20) .
Titration of virus in infected mouse lungs. At various times postinfection, the mice were sacrificed and the lungs were removed. Lungs were homogenized in growth medium by using an MSE overhead homogenizer and sonicated with an ultrasonic probe, and the particulate material was removed by centrifugation (6,000 x g for 5 min). The amount of infectious virus was titrated by infecting Vero cells, grown in 96-well microtiter plates, with 100 ,l1 of doubling dilutions of the lung suspension in growth medium.
Preparation of radiolabeled antigen extracts, immunoprecipitation, and SDS polyacrylamide gel electrophoresis. The methods used have been described elsewhere (19) . In the preparation of soluble antigen extracts, the immunoprecipitation buffer used consisted of 10 mM Tris hydrochloride (pH 7.2), 5 mM EDTA, 0.5% Nonidet P-40, 0.1% SDS, 0.65 M NaCl, and protease inhibitors (1 mM phenylmethylsulfonyl fluoride and 10 mM NaS2O5). (Fig. 3) . Since P815 cells express class I but not class II MHC antigens, the killing observed was mediated through class I-restricted CTLs. (Table 2 ). Even by 6 days postinfection, a small amount of neutralizing antibody could be detected in a number of mice after transfer of immune lymphocytes. It should be noted that one of the mice which received immune lymphocytes had not cleared the infection by 10 days postinfection (Fig. 1, mouse 9 ). However, since this mouse did not make an antibody response to SV5 ( neutralized virus infectivity (19) . A pool of these antibodies was made and passively transferred both before and after infection of immunodeficient mice. This experiment was repeated multiple times. Although there were slightly reduced amounts of virus antigen in the mice that received the pool of MAbs, these experiments clearly demonstrated that the presence of high-titer serum antibody did not have a major influence on the rate of clearance of SV5 from infected lungs (Fig. 4) despite the facts that (i) both anti-HN and anti-F antibodies were detected by immunoprecipitation at the time of sacrifice of these animals ( Fig. 5) and (ii) the measurable levels of serum-neutralizing antibody were higher, both immediately after passive transfer and at the time of sacrifice of the animals, than those in the mice which successfully cleared the virus infection after transfer of immune lymphocytes (compare Tables 2 and 3 ).
The inability of neutralizing antibody alone to play a major role in clearing virus was confirmed by purifying B cells from immune spleens and transferring them to immunodeficient mice immediately after infection with SV5. The B cells were purified by panning immune lymphocytes on immunoabsorbent monolayers to which sheep anti-mouse immunoglobulin Fig. 1 .
b Values for mice 1 to 8 on both days were <20.
had been bound (17) . This purification procedure resulted in a population of lymphocytes that were more than 97% pure for B cells as determined by FACScan analysis. A total of 4 x 107 purified B lymphocytes were transferred intraperitoneally to immunodeficient mice. After infection with SV5, these mice made very high levels of neutralizing antibody (1/1,280 to 1/5,120). However, they failed to clear the virus infection (Fig. 6 ). From these and our previous results, it appeared likely that T cells were responsible for the clearance of virus. This supposition was supported by the finding that immune spleen cells that had been depleted of adherent cells and 95% of B cells by panning were still capable of clearing SV5 from the lungs of immunodeficient mice (data not shown; Fig. 7 ). To further examine the role of T lymphocytes in clearing SV5 infections, two series of adoptive transfer experiments were carried out. In the first series of experiments, CD4+ or CD8+ cells were sensitized for complement lysis and opsonization upon adoptive transfer by treating the lymphocytes with MAbs specific for these antigens before the transfer. This method has been shown to prevent graftversus-host reactions (6), and it is known that transfer of the antibodies alone depletes the respective populations of cells in vivo (7) . Although some degree of protection was still observed after treatment of the cells with the anti-CD8 MAb, it was significantly reduced. However, treatment of the lymphocytes with the MAb to CD4 had no measurable effect 1 to 3) or from mice to which unselected immune lymphocytes (tracks 4 to 6) or purified immune B lymphocytes (tracks 8 to 11) were adoptively transferred 2 h after infection.
of protection observed was due to CD4+ effector cells or low levels of contamination with CD8+ cells. Nevertheless, both sets of adoptive transfer experiment showed that CD8+ cells were the predominant cell type involved in clearing SV5 from infected mouse lungs. (Fig. 4 , tracks 6 to 9) to which MAbs to the HN and F proteins had been passively transferred before infection with SV5. The sera of control mice (Fig.  4 , tracks 1 to 5) had no detectable antibody to SV5 (data not shown). (Fig. 8) . In these experiments the B cells were not removed, and it is pertinent to note that the mice which received the lymphocytes that had been treated with the anti-CD8 MAb had the highest levels of neutralizing antibody (Table 4) but were the least protected.
In the second series of experiments, different lymphocyte populations were removed from immune spleen cells by panning on immunoaffinity plates. Initially more than 95% of B lymphocytes were removed by this method, and subsequently either CD4+ or CD8+ cells were depleted. An analysis of the resulting lymphocyte populations is shown in Fig. 9 . Immune cells from which more than 95% of B cells and CD4+ cells had been removed still efficiently cleared the virus infection. However, immune cells that were depleted of more than 95% B cells and CD8+ cells also enhanced the speed of clearance of virus, albeit to a lesser degree (Fig. 7) . From these results, it was not clear whether the small degree Adoptive transfer of immune lymphocytes to immunodeficient mice enhanced the speed with which these animals cleared the SV5 infection. Depletion of CD8 + cells but not B cells from immune splenocytes dramatically reduced their ability to clear the virus infection. These results demonstrated that virus clearance was primarily mediated by CD8+ effector cells. However, in these studies it appeared that CD4+ cells also had some antiviral activity. In vivo, the T cells could mediate their activity either directly through their cytolytic activities or through the production of antiviral lymphokines. CTL activity in vitro suggests that in vivo CD8+ cells may also mediate their antiviral effect directly through their cytotolytic activity. With regard to the role of antibody in this system, the presence of serum-neutralizing antibody in immunodeficient mice had little effect on the speed of clearance observed. The small effect observed may be explained if neutralizing antibody inactivated any infectious virus produced during the infection, thus reducing the spread of virus in the lungs, rather than being involved in the elimination of persistently infected cells. The observation that serum-neutralizing antibody had little effect in the clearance of SV5 from infected mouse lungs is at odds with multiple studies demonstrating that transfer of neutralizing MAbs can protect experimental animals from infection with other paramyxoviruses, as measured by infectious titer assays (8, 13, 23, 28) . Part of the explanation may be that in these latter systems the infection is productive, with large amounts of infectious virus being produced. Obviously, in such systems neutralizing antibody may well prevent spread of virus within infected tissues and hence be protective. aCorresponding to the lanes in Fig. 8 . One possible explanation is that persistent infections occur at immunologically privileged sites. However, this is unlikely to be the complete explanation. Since MHC antigens are extremely polymorphic (22) , different individuals in a heterologous population may recognize different T-cell target antigens, depending on their histocompatibility status (2, 4, 10, 15) . Consequently, it may be that persistent infections develop in individuals with specific human leukocyte antigen repertoires. As shown here and elsewhere (Randall and Russell, in press), in persistent paramyxovirus infections the virus genome must be transcribed and replicated, even though little or no infectious virus need be produced. Therefore, the virus must retain the capacity to encode those virus proteins (NP, P/V, and L) involved in transcription or replication. However, mutations or deletions in other virusspecified proteins ( 
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